WORK Medical Technology Group Ltd. Class A (WOK)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 53 | 46 | 20 | 14 | 12 | 10 | 11 | - |
| Operating profit | $m | -2 | -4 | ||||||
| Net profit | $m | 1 | 6 | 1 | 0 | -3 | -1 | -4 | - |
| EPS reported | $ | -37.01 | -208.2 | ||||||
| Operating cashflow per share | $ | 21.55 | 60.28 | ||||||
| Capex per share | $ | 4.60 | 12.86 | ||||||
| FCF per share | $ | 16.95 | 47.42 | ||||||
| Free cash flow | $m | 5 | -6 | ||||||
| Net debt | $m | 2 | 3 | ||||||
| Book value equity | $m | 18 | 30 | ||||||
| Book value per share | $ | 63.30 | 1,747 | ||||||
| Number of shares | m | 0.29 | 0.02 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 1,183.20 | 720.41 | ||||||
| P/S LTM | x | 2,203.94 | 2,025.21 | ||||||
| P/FCF LTM | x | 4,419.18 | -3,859.22 | ||||||
| EV/EBITDA LTM | x | 63,966.33 | -6,806.73 | ||||||
| EV/Sales LTM | x | 2,204.18 | 0.75 | ||||||
| Earnings Yield LTM | % | -0.00% | -4.99% | ||||||
| FCF Yield | % | +0.02% | -0.03% | ||||||
| Quality | |||||||||
| ROE | % | -5.85% | -6.86% | ||||||
| ROIC | % | -9.04% | -9.04% | ||||||
| Operating margin | % | -25.34% | -25.34% | ||||||
| Gross margin | % | +23.81% | +23.81% | ||||||
| FCF/Sales | % | +49.87% | +49.87% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -14.41% | -6.85% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.76 | -0.85 | ||||||
| Net Debt/EBITDA | x | 6.95 | -1.69 | ||||||
| EBIT/Net interest | x | -4.96 | -4.96 | ||||||
| Net debt/market cap | % | +0.03% | +1.28% | ||||||
| Net debt/Equity | x | 0.13 | 0.11 | ||||||
| Gross debt/equity | x | 0.35 | 0.22 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
WORK Medical Technology Group Ltd. Class A (WOK)
No price history available.
Not enough data to calculate KvantraRank
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free